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Abstract:  
Background & Aims: Acute kidney injury (AKI) is a serious complication of liver surgery and 
associated with significant morbidity and mortality. The incidence of AKI following hepatic 
surgery can be as high as 94%, with highest rates seen following orthotopic liver 
transplantation, particularly when extended criteria grafts are used. Strategies to identify 
patients at risk of AKI may enable early interventions to prevent or minimise AKI. 
Methods: A systematic review was conducted using PubMed, Medline, Cochrane and Google 
Scholar databases for literature reporting models predicting risk of AKI following liver 
surgery.  All were scrutinised for model variables, performance of the models, and validation 
strategies in order to identify key factors associated with increased risk. 
Results: From an initial pool of 1432 results, seven articles were identified which reported 
risk prediction models for AKI. These included articles using either an equation-based model 
or point-based system for risk prediction and two studies were clinically validated. Whilst 
predictive variables varied from study to study, factors relating to liver function (MELD), 
cardiovascular integrity and extent of surgical blood loss were important for determining risk.  
Conclusions: This study has identified key discriminating variables that show promise in 
predicting risk of AKI in patients undergoing hepatic surgery. However it is important to note 
that a robust risk prediction model derived from a large prospective cohort study, recruiting 
patients from multiple centres who experience specific types of hepatobiliary intervention is 
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currently lacking. Thus further studies are required to develop a robust model that can be 
applicable across multiple patient populations with different underlying aetiologies.  
Keywords  
Hepatic; renal; acute injury; prediction; model 
 
1. Introduction 
Acute kidney injury (AKI), is characterised by a rapid (hours to days) decrease in renal function 
and is associated with poor estimated Glomerular Filtration rate (eGFR), longer hospital stay, 
development of chronic kidney disease (CKD) and increase in short- and long-term mortality in 
hospitalised patients [1, 2]. Recent data reveals that up to 40% of AKI cases in acutely hospitalised 
patients occur in perioperative settings, and are a significant contributing factor to high morbidity 
and mortality [3]. Since overall perioperative mortality in the AKI group may be over seven times 
greater than the adjusted non-AKI cohort undergoing cardiac surgery [4] much effort has been 
given to predicting risks of AKI following cardiac surgery. Indeed, Huen and Chirag [5] identified 
seven different risk stratification models for AKI following cardiac surgery in their recent 
systematic review of which four of the models have been independently validated in individual 
cohorts.  However, AKI is also an important factor in non-cardiac and general surgical patients [6] 
with the incidence of AKI reported to be up to 22% depending on the type of surgical procedure 
[7]. One study of 457,656 patients who underwent non-cardiac and non-vascular abdominal 
surgery revealed a 30 day mortality of 31% in patients developing AKI compared to 1.9% in the 
non-AKI cohort after being adjusted for confounding factors [8]. A systematic review of the risk 
prediction models for AKI following major non-cardiac surgery (including general abdominal 
surgery and liver surgery) identified seven models based upon both preoperative and 
interoperative factors [6]. However, none of the prediction models have been validated in 
independent cohorts and to date there are no studies reporting clinical implementation or 
analyses of clinical impact. Importantly data on AKI incidence and outcomes following 
hepatobiliary surgery is scarce, with no robust study including outcomes following both transplant 
and non-transplant procedures. 
Some studies suggest that incidence of AKI following specific hepatobiliary surgery types is 
comparable to cardiac surgery and can be as high as 94% [9]. Of note, variation in incidence is 
influenced by type of hepatobiliary surgery performed and the diagnostic criteria used to 
characterise AKI, although increase in baseline serum creatine values by above 50% is commonly 
used. Highest incidences of AKI are seen following orthotopic liver transplantation, and in common 
with cardiac surgery, this is associated with increased length of hospital stay, mortality and 
increased costs [10]. With the current growing burden of liver disease [11] driving increases in 
liver transplantation [12] and resection surgery [13], the number of patients undergoing liver 
surgery is increasing annually. Despite this, prediction of AKI in patients undergoing specific 
hepatic or biliary interventions has not received as much attention. Although risk factors for AKI 
following hepatobiliary surgery are reported, [14-16] the risks vary dependent on the nature of 
the surgical intervention, as well as diagnostic criteria used and few authors have proposed risk 
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prediction models to aid with management of patients. Therefore, this review endeavours to 
collate the literature available on AKI prediction models to consolidate current understanding of 
risk of AKI following all types of liver surgery. Our aim was to develop a scheme to identify high-
risk patients, with a view to proposing potential preventative or early management interventions 
that could be undertaken to improve patient outcomes.  
Ethics Statement  
This work constitutes a systematic review of evidence carried out at the University of 
Birmingham. This article in part presents independent research funded by the NIHR Birmingham 
Biomedical Research Centre at the University Hospitals Birmingham NHS Foundation Trust and the 
University of Birmingham. The views expressed are those of the author(s) and not necessarily 
those of the NHS, the NIHR or the Department of Health. 
2. Materials and Methods 
A comprehensive literature search of four databases was conducted followed by a three stage 
review process to identify the pertinent literature in accordance with the PRISMA standard [17]. 
The search was conducted with strict adherence to our pre-specified criteria to exclude irrelevant 
titles and ensure consistency. Pubmed, Medline, Cochrane and Google Scholar databases were 
searched using four search themes: ‘acute kidney injury’, ‘surgery’, ‘prediction’ and ‘risk score’, 
and all variations to identify studies which reported prediction models for the risk of AKI in post-
operative patients (Table 1).  
2.1 Study Selection Criteria 
The first stage of the review was an exclusion based on article titles. Exclusion criteria included; 
all foreign language articles, studies reporting data from non-human subjects, duplicate articles, 
articles reporting non-primary data (e.g. review articles) and studies which obtained data from 
paediatric patients or those under 18 years of age.  The second stage of the review was exclusion 
based on the abstract, and additional exclusion criteria were imposed. Here studies which 
contained qualitative data, measured primary outcome as mortality, utilised previously published 
datasets, reported patients with pre-existing renal disease, reported cardiac and/or vascular 
surgery, reported only the incidence of AKI without risk factors or reported occurrence of renal 
injury greater than 30 days post-operation were excluded. Articles which reported risk factors of 
AKI in non-surgically managed patients were excluded regardless of whether they were considered 
or listed for surgery. Articles were included if they contained a model stratifying risk factors for AKI 
after major liver surgery, including but not limited to recipients of whole liver grafts, recipients of 
split grafts, live liver donors and patients undergoing liver resections for both neoplastic and non-
neoplastic lesions.  
2.2 Data Extraction 
All studies were scrutinised for the model variables applied, validation strategies and predictive 
performance of model (area under curve (AUC)).  
Table 1 Database search terms. 
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MeSH search terms 
‘acute kidney injury’ OR ‘acute kidney failure’, ‘acute renal failure’, ‘acute 
renal injury’, ‘renal insufficiency’, ‘acute kidney 
damage’, ‘renal replacement therapy’ 
AND   
‘surgery’ OR ‘surgical procedure’, ‘operation’, ‘preoperative’, 
‘postoperative’, ‘perioperative’ 
AND   
‘prediction’ OR ‘predict’, ‘predictive’, ‘prognosis’, ‘prognostic’ 
AND   
‘risk score’ OR ‘risk model’, ‘risk stratification’, ‘risk algorithm’, 
‘risk equation’, ‘risk index’, ‘predictive index’ 
Table summarising the key words and terms used for identification of relevant articles 
3. Results 
3.1 Studies Considered 
The search yielded 1432 articles from the four databases of which 1194 results were excluded 
by title in the first stage of screening. The abstracts of the remaining 238 results were reviewed 
and 199 were excluded as they included data from patients undergoing cardiac surgery, did not 
measure outcome in terms of acute renal injury, included paediatric patients or used secondary 
data. The remaining 39 articles were included for full text review (Figure 1). Overall, the search 
yielded a total of seven articles proposing ten different models for predicting risk of AKI following 
liver surgery. Collectively, the seven articles include data from 1989 patients recruited from seven 
centres across six countries (USA, China, Germany, Switzerland, Japan and Korea). The results are 
summarised in Table 2. Six [18-23] of the seven remaining articles included cohorts of patients 
undergoing liver transplantation, of which two articles (Utsumi et al., [21] and Park et al., [22])  
exclusively included patients receiving transplantation from living donors. The seventh study 
(Slankamenac et al., [24]) was the only one to include patients who underwent any form of liver 
surgery (including liver transplantation) in their cohort. Interestingly, two of the studies [20, 22], 
proposed more than one risk prediction model. The number of patients included in the studies, 
including derivation cohort and validation cohort, ranged from 866 [18] to 71 [19] with the median 
being 200 [21]. Importantly, all included studies contained retrospectively collected cohort data 
from single centres (Table 2).  
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Figure 1 Preferred reporting items for systematic reviews and meta-analyses (PRISMA) 
flow chart for study selection. 
The flow chart summarises the steps taken to choose relevant articles and the number of 
articles included/excluded at each stage in our review process. 
3.2 Defining AKI and Prediction Variables 
The definition of AKI and outcome measures used, varied between the studies. Two studies [18, 
23] opted to define AKI as the need for renal replacement therapy (RRT). Rueggeberg et al. [19] 
also defined AKI in their study based on need for RRT, but also combined this with an increase in 
serum creatinine (SCr).  Xu et al. [20] and Slankamenac et al. [24] defined AKI using the Acute 
Kidney Injury Network (AKIN) classification also based on an increase in SCr above the 
preoperative baseline [25]. In contrast, Utsumi et al. [21] and Park et al. [22] opted to define AKI 
using the Risk, Injury, Failure, Loss, End-stage Renal Disease (RIFLE) criteria [26] categorising their 
AKI groups into further sub-categories.  
Variables that predict risk of AKI also differed between the studies and the four variables with 
the highest odds ratio are summarised in Table 3. These include factors such as Model for End-
stage Liver Disease (MELD) score and other hepatic parameters, extended ITU stays, concurrent 
disease and amount of blood products needed during the procedure. Park et al. [22] factored in 
the greatest number of variables at 20 for their primary model reducing that number to 14 and 10 
for their secondary and tertiary models, respectively. In contrast Xu et al. [20] considered the 
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fewest variables for their secondary model factoring only SCr and serum sodium concentrations. 
However, for their primary prediction score they include four factors, joint fewest with Sanchez et 
al. [18]. Four of the studies [18-20, 23] stratified the risks of AKI by using the values of the 
predictive variables in a model to calculate a risk score. Three studies [18-20] developed a 
threshold where a superthreshold score indicates risk of AKI or need for RRT.  Hence Kim et al. [23] 
developed a nomogram which calculates risk of AKI using an equation score based on a hepatic 
encephalopathy score, use of deceased donor liver, MELD, intraoperative blood loss and cancer as 
the underlying cause of surgery. In contrast, other investigators [21, 22, 24] developed a points-
based system where each predictive variable is attributed a certain number of points, the total of 
which correlates with a percentage risk of AKI. The four variables with the highest predictive 
values (Table 3, measured as either odds ratio or regression coefficient) from each of the primary 
prediction models differed between studies (greater than 3 days of intensive care unit (ICU) stay  
[18], diagnosis of hypertension [19], intraoperative oliguria [20], serum alanine transferase (ALT) 
above 35 IU [24], intraoperative blood loss of more than 55ml/kg [21], presence of hepatic 
encephalopathy [23] and transfusion of more than six units of cryoprecipitate [22])  with no single 
variable appearing in the top four of all prediction models proposed (Table 3). However as noted 
above, MELD score, was the most frequent variable appearing in the top four predictive variables 
of four studies [[18, 21-23], and similarly factors relating to blood loss or replacement and 
cardiovascular parameters were common in most models.  
3.3 Validation 
Development of a predictive model that is robust when applied to an external cohort, suggests 
it is likely to be prognostic across a range of patient populations. Hence, previous studies using 
prediction models developed to identify risks of AKI following cardiac surgery [27, 28] incorporate 
external validation to assess their predictive power. In contrast only half of the risk prediction 
models in the context of liver surgery considered here [18-20] underwent clinical validation. 
Models from three other studies [22-24] were only validated statistically, and interestingly one of 
the studies [21] did not carry out any internal validation at all.  
In summary, the evidence shows that the most significant variables for predicting risk of AKI in 
hepatobiliary surgery are greater than three-day stay in ICU, intraoperative oliguria, major 
intraoperative blood loss and pre-operative diagnosis of hypertension. The MELD score is also 
highly relevant as it is a contributing element in the majority of the models. The available evidence 
suggests that the best model to accurately predict risk is that proposed by Sanchez et al. [18].  
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Table 2 Summary of articles proposing risk prediction models. 
  Sanchez et al.  
(2004) [18] 
Rueggeberg et 
al. (2008) [19]  
Xu et al. (2010) 
[20] 
Slankamenac et 
al. (2013) [24] 
Utsumi et al. 
(2013) [21] 
Kim et al. (2014) 
[23] 
Park et al. 
(2015) [22] 
Prediction model               
Patient population Patients 
undergoing 
cadaveric liver 
transplant 
Patients 
undergoing live 
donor (17) and 
cadaveric (54) 
liver transplant 
Patients 
undergoing 
cadaveric liver 
transplant for 
benign end stage 
liver disease 
Patients 
undergoing any 
liver surgery 
Patients 
undergoing live 
donor liver 
transplants 
Patients 
undergoing live 
donor (110) and 
cadaveric (47) 
liver transplant 
Patients 
undergoing live 
donor liver 
transplants 
No. of patients 
(Centers) 
 
866 (1) 71 (1) 146 (1) 549 (1) 200 (1)  157 (1) 538 (1)  
Design of study Retrospective 
cohort 
 
Retrospective 
cohort 
Retrospective 
cohort  
Retrospective 
cohort 
Retrospective 
cohort 
Retrospective 
cohort 
Retrospective 
cohort 
Measured outcome RRT SCr >132 µmol/l 
and RRT 
SCr >1.5mg/dl 
with increase 
of >50% above 
baseline 
SCr >0.3mg/dl 
above baseline 
or >50% above 
baseline  
RIFLE criteria RRT RIFLE criteria 
Derivation cohort n = 724 
 
n = 71 n = 102 n = 549 n = 200 n = 157 n = 538 
Derivation period 1996 - 2001 Aug 2000 – Jun 
2001 
Jan 2004 - Sep 
2005 
Jul 2002 – Oct 
2007 
Aug 1996 - Jan 
2011 
Jan 2008 – Dec 
2011 
2007 - 2013 
Incidence of AKI (%) N/A N/A 33 (32.4%) 82 (14.9%) 121 (60.5%) N/A 147 (27.3%) 
Median outcome 
time 
  5 days 2 days         
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No. needing RRT (%) 87 (12.0%) 13 (18.3%) 10 (9.8%) 23 (0.04%) 30 (15%) 42 (27.3%) 34 (6.3%) 
1yr mortality AKI 
(no AKI) 
50.9% (9.0%) 39.1% (5.6%) 29.9% (7.7%) 23% (0.8%) 15.8% (3.2%) 50% (0.1%) 19.7 % (13.7%) 
Predictor selection Logistic 
regression 
(p < 0.05) 
Logistic 
regression      (p  
< 0.15) 
Logistic 
regression 
(p < 0.05 
Logistic regression 
(p < 0.15) 
Logistic 
regression 
(p < 0.05) 
Logistic 
regression 
(p < 0.05) 
Logistic 
regression 
(p <0.05) 
Internal Validation               
Validation  Temporal 
cohort (142) 
Latter cohort 
(167) 
Random split 
30.0% (44) of 
derivation cohort  
Cross validation  
(5-fold) 
  Bootstrap 
validation 200 
repetitions 
Cross 
validation 
(10-fold) 
Validation period 2002 Jul 2001 – Dec 
2003 
Nov 2005 - Jul 
2006 
Jul 2002 – Oct 
2007 
  Jan 2006 – Dec 
2011 
2007 - 2013 
Performance               
Outcome incidence 
(%) 
20 (14%) 23 (14%) 12 (27.3%)     42 (27.0%)   
Performance 
statistic 
AUC 
0.905 
AUC  
0.91 
AUC 
Model 1= 0.908; 
2= 0.765 
AUC 
0.79 [95% CI (0.73-
0.84)] 
  AUC 
0.90 
AUC 
Model: 1= 0.85; 
2= 0.86; 3=0.86 
No. of variables 4 6 Model 1= 2; 2= 4 10 5 5 Model 1= 20; 
2= 14; 3= 10  
Prediction tool 
details 
Equation, 
threshold 
score predicts 
need for RRT 
Equation, 
threshold score 
predicts risk of 
AKI  
Equation, 
threshold score 
predicts risk of 
AKI 
Points system, 
with total 
correlating with 
percentage risk of 
AKI 
Points system, 
with total 
correlating with 
percentage risk of 
AKI 
Equation, with 
results used to 
interpret 
nomogram  
Points system, 
with total 
correlating 
with 
percentage risk 
of AKI 
Detail of the studies used for assessment of risk prediction models. Data includes indication of study size, and validation/performance assessment 
used. SCr- Serum creatinine, AUC- Area under curve, RRT- Renal replacement therapy, RIFLE- Risk Injury Failure Loss End-stage renal disease. 
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Table 3 Summary of the four predictive variables with the highest odds ratio in each study. 
  Sanchez et al. 
(2004) [18] 
Rueggeberg et 
al. (2008) [19] 
Xu et al. (2010) 
[20] 
Slankamenac 
et al. (2013) 
[24] 
Utsumi et al. 
(2013) [21] 
Kim et al. 
(2014) [23] 
Park et al. 
(2015) [22] 
Predictive 
Variable 1 
>3 day ICU stay  
(OR= 10.23) 
Hypertension 
(β= 6.82) 
Intraoperative 
oliguria <60ml/hr  
(OR= 9.42) 
 
ALT >35IU/L 
(β= 1.21) 
Intraoperative 
Blood 
loss >55ml/kg 
(OR= 3.70) 
Hepatic 
encephalopathy 
(OR= 5.47) 
Cryoprecipitate 
transfusion > 
units 
(OR= 7.42) 
Predictive 
Variable 2 
SCr >1.3mg/dL 
(OR= 3.57) 
Intraoperative 
MAP 
<50mmHg 
(β= 5.42) 
 
Intraoperative 
hypotension 
(OR= 4.67) 
Cardiovascular 
Disease 
(β= 1.19) 
Diabetes 
mellitus 
(OR= 3.23) 
Cadaveric graft 
(OR= 3.47) 
Blood 
loss >60ml/kg 
(OR= 6.95) 
Predictive  
Variable 3 
BUN >27mg/dL 
(or= 2.68) 
Hepatitis B/C 
(β= 4.96) 
SCr >1.2mg/dL 
(OR= 3.03 
Hepaticojejun-
ostomy  
(β= 0.93) 
GW/RBW, % 
<0.7 
(OR= 3.10) 
Blood 
loss >1000ml 
(OR= 1.16) 
Platelet 
transfusion >6 
units 
(OR= 5.80) 
 
Predictive 
Variable 4 
MELD score > 
21 
(OR= 2.50) 
Units of RBC 
required 
(β= 0.60) 
Intraoperative 
noradrenaline 
(OR= 0.09) 
Oliguria 
<400ml/24hr 
(β0.92) 
MELD 
score >20 
(OR= 2.96) 
MELD score >15 
(OR= 1.09) 
MELD score >20 
(OR= 2.97) 
Detail from the final seven studies examined illustrating which predictive variables were considered most important by the authors. SCr- Serum 
creatinine, BUN- Blood urea nitrogen, MELD- Model for end-stage liver disease, MAP- Mean arterial pressure, ALT- Alanine transferase, GW/RBW- 
Graft weight/recipient body weight percentage.
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4. Discussion 
Incidence of AKI following liver surgery can range from 12-94% in the post-operative period [9, 
29-31] and has a significant impact on mortality, length of hospital stay and cost to healthcare 
providers [9, 10].  Furthermore, the severity of post-operative AKI correlates with increased 
mortality [32]. Thus reducing the risk of AKI or indeed, minimising severity of AKI must be the aim 
for healthcare providers. Identification of a robust prediction score applicable to a wide surgical 
population demographic is necessary to permit interventions to be undertaken preoperatively, 
intraoperatively or postoperatively to minimise the risks of AKI and thus improve patient 
outcomes. Preoperatively, concurrent chronic illnesses such as diabetes, hypertension and 
cardiovascular disease should be managed to ensure blood sugars, blood pressures and cardiac 
output are strictly regulated to maximise perioperative fitness and chance of survival. Factors such 
as intraoperative blood pressure, use of noradrenaline and urine output can be optimised 
therapeutically to ensure they are within ideal parameters during the operation and strategies 
should be undertaken to minimise perioperative blood loss. Postoperatively, strategies such as 
one to one nursing and presence of hepatobiliary surgeons on site throughout recovery would 
assist with maintenance of fluid status and hemodynamic stability. However such measures can 
only be implemented once the risk of AKI is identified to avoid under-managing those at high risk 
and over managing low risk patients. Patients who are not at high risk of AKI following liver 
surgery may be managed more conservatively to ensure minimum iatrogenic harm is caused and 
management is cost-effective.   
For any risk prediction model to be successful, it should be applicable to a general population. 
Consequently, articles including data from paediatric patients were excluded from our analysis, as 
critically ill children tend to be more responsive to haemodynamic and nephrotoxic insults that 
usually follow paediatric liver surgery [33, 34] and their risk of AKI is not representative of the 
adult population. Study population size is also important, with variability between cohorts making 
comparison of currently available predictive models difficult. Studies appraised here had patient 
numbers ranging from 866 [18] to less than 100 [19] patients, but  these are eclipsed by the vast 
cohort sizes used by studies comparing risk prediction models for non-liver surgery [35, 36]. Ideally 
data derived from multiple centres and different patient ethnicities would be used in a risk-
prediction model to be considered as representative of a wider population. All seven studies 
critiqued in this systematic review included patients from single centres and none of the models 
were externally validated. Thus, models should be tested further to ensure for example, that 
predications based on the US-based studies of Sanchez et al. are as effective as predicting risk of 
AKI in Korean patients [22].  
Similarly the indication for liver surgery for patients from six [18-23] of the seven studies 
included here was liver transplantation, a major procedure which has direct effects on renal 
function [37], as would the presence of cirrhosis and portal hypertension prior to surgery [38]. The 
mortality of patients undergoing liver transplant can be up to eight-fold greater if AKI develops [39] 
so early prediction and optimised management of AKI could have profound effects. Nevertheless, 
this suggests caution when predicting risk of AKI in patients undergoing non-transplant liver 
surgery. Causes for non-transplant  liver surgery will include resection of primary and secondary 
tumours [40, 41], and a significant proportion of these patients may require systemic 
chemotherapy [42] with anti-cancer agents, some of which are nephrotoxic [43, 44]. These 
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patients may have an increased predisposition to suffering AKI and this should be factored in 
when developing specific risk prediction models.  
Even mild post-operative AKI can have a significant effect on mortality and morbidity [45]. 
Outcome measures vary between studies of risk-prediction with some authors [[18, 23]] 
considering need for renal replacement therapy (RRT) and others [19-22, 24] varying degrees of 
AKI. AKI was classified using the Risk, Injury, Failure, Loss and End stage renal disease (RIFLE) 
classification system [26], the Acute Kidney Injury Network (AKIN) [25] classification and other 
measures. The RIFLE classification is based on measuring serum creatinine (SCr) or urine output. 
SCr is universally used for assessing renal excretory functions as part of the widely used Cockcroft-
Gault equation [46]. Urine output is used in the acute, post-operative and ICU settings, and is 
more sensitive to renal haemodynamic changes [47]. The AKIN classification is based on a 
modified version of the RIFLE criteria where an absolute increase in SCr is a criterion for AKI [25]. 
In contrast to need for RRT, both RIFLE and AKIN criteria enable AKI to be classified across a 
spectrum of severity. This means that models derived from cohorts with severe AKI (needing RRT) 
may need adapting before they can be applied to patients who suffer mild or moderate AKI.  
Hence a standardised endpoint is needed to determine the severity of AKI for future model-
development and ideally this would incorporate either RIFLE- or AKIN-classified AKI as an endpoint 
to ensure patients at risk of mild AKI are identified. 
The selection of predictive factors used to derive risk models is very important. The aim should 
be to include only relevant factors with a high predictive power. Only one of the studies [24] used 
bootstrap resampling to select their predictor variables, with other studies [18-23] using step-wise 
regression techniques, and there was inconsistency between studies that have used preoperative, 
intraoperative and postoperative variables. Model for End-stage Liver Disease (MELD) was most 
consistently used across the studies. This is widely used to predict prognosis of patients with liver 
disease and to prioritise patients for liver transplants [48, 49], but as SCr concentration, bilirubin 
and international normalised ratio (INR) are incorporated, it is plausible that MELD score would 
also correlate with risk of AKI [50]. Studies predicting risk of AKI following cardiac surgery have 
used more novel biomarkers such as neutrophil gelatinase-associated lipocalin (NGAL) and 
inflammatory regulators such as interleukin-18 (IL-18) [51] which showed some predictive value. 
Neither marker is cardiac specific, but NGAL levels have been associated with higher risk colorectal 
cancers in a pilot surgical study [52], suggesting there may also be utility in predicting risk 
following hepatobiliary surgery. Further innovative imaging strategies to identify AKI and predict 
risk have been summarised by Hobson et al. [53] which include computational tomography (CT), 
magnetic resonance imaging (MRI), Doppler ultrasound and contrast enhanced ultrasound among 
other techniques, which may have value in the future.  
All studies were scrutinised for model variables applied, presence of validation strategies and 
predictive performance of model (area under curve [AUC]). While AUC, sensitivity, specificity and 
predictive values are important in development of prediction models, caution must be taken when 
comparing model performances as these values are sensitive to the size of cohorts and incidence 
of the predicted outcome [54]. Using only two variables, the ‘preoperative model’ [20] achieved 
an AUC of 0.765 suggesting it was a reasonable test. The ‘post-operative’ model from the same 
authors [20] achieved an AUC of 0.908 using four (one pre-operative and three intraoperative) 
variables; suggesting use of a greater number of factors improves predictive power. However, Park 
et al. [22] suggest no improvement in discriminative power using a greater number of variables. 
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They attained an AUC of 0.85 using 20 variables (eight preoperative, 11 intraoperative and one 
postoperative) in their primary model and an AUC of 0.86 using 14 and 10 variables for their 
secondary and tertiary models, respectively [22]. Similarly Rueggeberg et al. [19] achieved an AUC 
of 0.91 using just six variables (three pre-operative and three intraoperative) further suggesting 
that increasing the variables does not equate to greater discriminative power. There was no 
identifiable correlation between the proportion of variables that are preoperative, intraoperative 
or postoperative with the performance of the model.  
Four of the studies [18-20, 23] used predictive variables to form an equation from which a score 
was obtained. Of those four, three studies [18-20] identified a risk threshold above, which a 
patient is at risk of AKI (or RRT). Dichotomising the results of the prediction model into ‘at risk’ and 
‘not at risk’ has obvious benefits as it is likely to be quicker to calculate, doesn’t require expert 
judgement (making it easier for use by supporting healthcare professionals) and makes 
justification for clinical decisions more straightforward. In reality however, assessment it is not 
black and white and patients with identical model scores will have variations in the actual risk of 
AKI. Indeed, those who develop AKI will have different outcomes. Thus to make the dichotomous 
model effective, there has to be a precipitous increase in risk of AKI at the threshold score. As an 
alternative, the points based system used by the remaining three studies relies on the judgement 
of clinicians to decide where risk is deemed significant and where an intervention is indicated.  
5. Conclusion 
Our analysis has shown that whilst predictive variables vary from study to study, factors relating 
to liver function (MELD), cardiovascular integrity and extent of surgical blood loss are significant 
(Table 3). Ten articles could potentially have met the review criteria however one [55] did not 
include an equation, algorithm or scoring method and another [56] presented a robust study but 
included patients with pre-existing chronic kidney disease (CKD) and so was excluded. Seven 
articles proposed models which fit our criteria, but all had individual limitations and improvements 
could be made. Taking into consideration cohort size, the model design, statistical performance 
and ease of applicability, the most appropriate models are those proposed by Sanchez et al. [18] 
and Park et al. [22] although the Park study remains to be externally validated, and no single ideal 
model was identified. To address the need to identify those at highest risk of AKI post-operatively 
in the ever growing pool of patients experiencing hepatatic surgery, further evaluation is required.  
Ideally a prospective cohort study, recruiting patients from multiple centres, including risk factors 
with high predictive power, and which measures both onset of AKI and mortality is required. 
Furthermore, external validation should be carried out in multiple independent cohorts if findings 
are to be included as part of clinical guidelines for managing patients undergoing major 
hepatobiliary surgery. 
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